StockDrifts LogoStockDrifts

Mangrove Partners Im 13F Portfolio

Portfolio Manager
Mangrove Partners Im LLC
Performance
+10.48% (2026 Q2)
AUM (13F)
$1.52B
# of Holdings
426
Performance Rank
Allocation (Top 20)
61.92%
Latest filing
Q2 2026

2026 Q2 ยท 13F Analysis

Mangrove Partners Cuts Ethereum to Fund a Networking Bet

Published September 20, 2026 ยท Based on the SEC 13F filing for 2026 Q2

Key takeaways

  • Ethereum cut funds a networking and components build.
  • Vistance Networks is now the second-largest position at 6.01%.
  • New money goes to healthcare, autos and small-cap beta.
  • Winners get pared for sizing, not for thesis breaks.
  • Roughly 8% of the book sits in blank-check trusts.

The thesis in one look

This quarter's defining move is a handoff, not a hedge. Mangrove Partners cut its Grayscale Ethereum Staking stake by 37.2% while turning a token 11,942-share stub of Vistance Networks into a $91.5M position worth 6.01% of the book โ€” a liquid digital asset traded for physical network plumbing.

The rest of the quarter reads the same way: a $1.52B 13F book, top-10 concentration of 38.1%, a 10.48% gain in the period, and fresh money going into businesses the market has already marked down. New entries include Acadia Healthcare, Aptiv, Apartment Investment & Management, Greif and the iShares Russell 2000 ETF.

The core is unchanged value plus special situations. Indivior remains the largest holding at 7.22% and sits 188.0% above the fund's average cost; Atmus Filtration, Vistance and Millicom round out the top five. There is no mega-cap technology anchor and no index-like ballast, which is the point: this is a stockpicker's book where the biggest bet is a leveraged connectivity supplier most generalists will not own.

Portfolio concentration
INDV โ€” 9.4% ($109.83M)VISN โ€” 7.8% ($91.48M)ATMU โ€” 5.3% ($61.76M)FLYW โ€” 4.5% ($52.43M)TIGO โ€” 4.3% ($50.51M)REX โ€” 3.9% ($45.84M)KDP โ€” 3.8% ($44.67M)MRP โ€” 3.6% ($41.50M)ACHC โ€” 3.5% ($41.23M)PCG โ€” 3.5% ($40.60M)Other โ€” 50.3% ($587.51M)
50%in top 10
  • INDV9.4%
  • VISN7.8%
  • ATMU5.3%
  • FLYW4.5%
  • TIGO4.3%
  • REX3.9%
  • KDP3.8%
  • MRP3.6%
  • ACHC3.5%
  • PCG3.5%
  • Other50.3%

Performance History

Performance Metric3-Year Annualized3-Year Cumulative5-Year Annualized5-Year Cumulative
Top 20 Holdings Weighted+28.17%+110.55%+23.50%+187.32%
Top 20 Holdings Unweighted+24.76%+94.19%+21.77%+167.73%

Fund Performance vs S&P 500

Exposure

Sector allocation

Current sector weights across the reported book, with the shift since last quarter.

Consumer Discretionary17.6%โˆ’0.9%
Unclassified14.0%+1.4%
Technology13.5%+7.9%
Health Care12.9%+0.9%
Industrials10.6%โˆ’2.6%
Finance8.0%โˆ’2.4%
Real Estate7.8%โˆ’0.6%
Utilities7.4%โˆ’1.8%
Telecommunications4.3%โˆ’1.1%
Consumer Staples3.8%โˆ’0.9%

Portfolio

Portfolio allocation

The fund's largest reported positions.

Top Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
INDV
INDIVIOR PHARMACEUTICALS INC
7.22%2.68M$109.8M
-2.40%(-65.70K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 2.74M shares2026-Q2: 2.68M shares
$13.62(+188.00%)
2026-06-30
VISN
VISTANCE NETWORKS INC
6.01%7.16M$91.5M
+59843.38%(+7.15M)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 14.6K shares2026-Q1: 11.9K shares2026-Q2: 7.16M shares
$15.20(-24.13%)
2026-06-30
ATMU
ATMUS FILTRATION TECHNOLOGIE
4.06%1.21M$61.8M
-7.91%(-103.99K)
2025-Q2: 1.10M shares2025-Q3: 1.33M shares2025-Q4: 1.32M shares2026-Q1: 1.32M shares2026-Q2: 1.21M shares
$25.59(+99.31%)
2026-06-30
FLYW
FLYWIRE CORPORATION
3.44%2.98M$52.4M
-1.03%(-30.92K)
2025-Q2: 0 shares2025-Q3: 2.90M shares2025-Q4: 2.98M shares2026-Q1: 3.01M shares2026-Q2: 2.98M shares
$12.66(+48.62%)
2026-06-30
TIGO
MILLICOM INTL CELLULAR S A
3.32%556.5K$50.5M
+0.00%(+0)
2025-Q2: 1.08M shares2025-Q3: 0 shares2025-Q4: 7.7K shares2026-Q1: 556.5K shares2026-Q2: 556.5K shares
$64.66(+45.20%)
2026-06-30
REX
REX AMERICAN RES CORP
3.01%1.02M$45.8M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 526.6K shares2025-Q4: 1.02M shares2026-Q1: 1.02M shares2026-Q2: 1.02M shares
$29.40(+53.48%)
2026-06-30
KDP
KEURIG DR PEPPER INC
2.93%1.36M$44.7M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 1.36M shares2026-Q2: 1.36M shares
$27.17(+15.72%)
2026-06-30
MRP
MILLROSE PPTYS INC
2.73%1.38M$41.5M
+0.00%(+0)
2025-Q2: 1.19M shares2025-Q3: 1.44M shares2025-Q4: 1.38M shares2026-Q1: 1.38M shares2026-Q2: 1.38M shares
$27.30(+11.10%)
2026-06-30
ACHC
ACADIA HEALTHCARE COMPANY IN
2.71%1.40M$41.2Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 25.6K shares2026-Q1: 0 shares2026-Q2: 1.40M shares
$26.06(+16.55%)
2026-06-30
PCG
PG&E CORP
2.67%2.41M$40.6M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 2.60M shares2025-Q4: 2.41M shares2026-Q1: 2.41M shares2026-Q2: 2.41M shares
$14.51(+22.95%)
2026-06-30

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
5
ACHCACADIA HEALTHCARE COMPANY IN2.7%
APTVAPTIV PLC2.5%
IWMISHARES TR1.8%
AIVAPARTMENT INVT & MGMT CO0.9%
+1 opened
Added to
4
VISNVISTANCE NETWORKS INC+59843.4%
BELFABEL FUSE INC+8105.8%
OTEXOPEN TEXT CORP+64.9%
BIOBIO RAD LABS INC+0.3%
Trimmed
5
ETHGRAYSCALE ETHEREUM STAKING-37.2%
ATMUATMUS FILTRATION TECHNOLOGIE-7.9%
AXINAXIOM INTELLIGENCE AC CORP 1-49.0%
INDVINDIVIOR PHARMACEUTICALS INC-2.4%
+1 more

Conviction build: connectivity hardware, components, cheap software

The biggest dollars went into connectivity and the components that feed it, not into anything compute-adjacent. That is a deliberate stance against the crowded AI trade, and several of these entries were bought before the tape agreed.

  • Vistance Networks: the quarter's headline add, $91.3M, now 6.01% of the book. Broadband access, fiber and wireless networking gear โ€” a levered turnaround trading 24.1% below the fund's $15.20 average cost.
  • Bel Fuse: the share count jumped 8,105.8% to a $30.5M position. Electronic components โ€” magnetics, connectors, power โ€” a picks-and-shovels way to own networking and defense buildouts, sitting 5.6% above cost.
  • Open Text: up 64.9% to $36.3M and held 2.4% below cost. Cheap enterprise information-management software with a deleveraging story attached.
  • Acadia Healthcare: new at $41.2M and 2.71% of the book. Behavioral-health capacity is genuinely supply-constrained, and this position is already 16.6% above cost.
  • Aptiv: new at $37.7M and 23.1% below cost. Auto electrical architecture was sold off on tariff and EV-slowdown fears; Mangrove is buying the cash flow, not the narrative.

Conviction

The big buys

The biggest dollar adds this quarter โ€” where conviction is rising.

PositionChangePortfolio weightValue
VISNVISTANCE NETWORKS INCAdded 59843.4%+$91.3M6.0%$91.5M
ACHCACADIA HEALTHCARE COMPANY INNew+$41.2M2.7%$41.2M
APTVAPTIV PLCNew+$37.7M2.5%$37.7M
BELFABEL FUSE INCAdded 8105.8%+$30.1M2.0%$30.5M
IWMISHARES TRNew+$27.7M1.8%$27.7M
OTEXOPEN TEXT CORPAdded 64.9%+$14.3M2.4%$36.3M
AIVAPARTMENT INVT & MGMT CONew+$13.2M0.9%$13.2M
GEFGREIF INCNew+$7.3M0.5%$7.3M

Dollar changes estimated at current prices (shares added ร— current price); top-50 current positions only.

The funding side: Ethereum pays, winners get pared

Almost all of the quarter's selling traces back to one line. Ethereum is the funding source: the Grayscale Ethereum Staking position fell 37.2%, a $19.8M reduction, and still sits at 2.2% of the book. Mangrove is monetizing an asset it no longer needs to make its point.

  • Grayscale Ethereum Staking: -37.2% and -$19.8M; still 2.2%, still 24.9% below the average cost. This is capital recycling as much as a crypto call.
  • Indivior: -2.4% and -$2.7M. A 188.0% winner trimmed at the margin; at 7.22% it stays the largest position, which makes this position-sizing rather than a broken thesis.
  • Atmus Filtration: -7.9% and -$5.3M, but still 4.06% of the book and 99.3% above cost.
  • Axiom Intelligence Acquisition: -49.0%. The blank-check stake was halved, consistent with a manager culling SPACs rather than adding them.
  • Flywire: -1.0%, effectively cosmetic, leaving a 3.44% position intact.

The pattern matters more than any single trim: the fund is not de-risking, it is raising cash from a position it has stopped believing in and from the edges of winners it still owns.

Exposure shift: tech up, income down, and two mislabeled buckets

The headline move looks dramatic and is narrower than it appears. Technology goes from 5.60% to 13.54% of the book, but that is essentially two names โ€” Vistance and Open Text โ€” and Vistance is a communications equipment company the screener happens to file under technology.

  • Consumer discretionary and industrials fall a combined 3.5 points, yet the industrials bucket is not industrial: it carries Bio-Rad, a life-sciences tools maker, and REX American Resources, an ethanol producer.
  • Utilities, real estate and financials drop roughly 4.8 points combined. Utilities at 7.39% includes ONEOK, a midstream pipeline operator rather than a regulated utility.
  • The real-estate sleeve is more than half payments software: Flywire and FIS together are 5.12 points out of that bucket's 7.82%. Genuine property exposure is Apartment Investment & Management at 0.87% plus Millrose, filed under finance.
  • Unclassified rises to 13.97%: Ethereum shrank, but the iShares Russell 2000 ETF, Bel Fuse and Greif were added.

Strip out the labeling noise and the real shift is away from rate-sensitive income and financials toward connectivity hardware, cheap software and selective small-cap cyclicals.

What this positioning is really betting on

Mangrove needs three things to work at once: a networking refresh cycle that rewards broadband and fiber suppliers, a re-rating of small-cap value, and company-specific deleveraging at Vistance. It is a bet that does not require AI capex to keep compounding, which is exactly why it looks odd next to most 13F books this quarter.

The clearest thing to watch is whether Vistance gets more money. At 24.1% below the average cost, a further add would be the strongest conviction signal this book can send; a stall or a trim would suggest the turnaround is drifting. Ethereum remains a live funding lever at 2.2% โ€” rallies there probably get sold into more value.

The blank-check sleeve, roughly two dozen vehicles worth about 8% of the book, is dormant optionality on deal flow rather than thesis exposure. Meanwhile Acadia, Aptiv and Apartment Investment & Management were all bought near or below cost, which tells you the manager is content to be early.

A book with 28.17% three-year annualized performance has earned the right to be early. What it cannot afford is being early on a levered supplier into a flat capex cycle.

Rotation

How the book's themes shifted

Portfolio weight by theme, this quarter versus last.

2026 Q12026 Q2Tech & telecomTech & telecom โ€” 2026 Q1: 10.99%10.99%Tech & telecom โ€” 2026 Q2: 17.87%17.87% +6.9ptConsumer & industrial cyclicalsConsumer & industrial cyclicals โ€” 2026 Q1: 31.65%31.65%Consumer & industrial cyclicals โ€” 2026 Q2: 28.2%28.2% โˆ’3.4ptHealth careHealth care โ€” 2026 Q1: 12%12%Health care โ€” 2026 Q2: 12.94%12.94% +0.9ptUtilities, REITs & financialsUtilities, REITs & financials โ€” 2026 Q1: 28.03%28.03%Utilities, REITs & financials โ€” 2026 Q2: 23.21%23.21% โˆ’4.8ptConsumer staplesConsumer staples โ€” 2026 Q1: 4.77%4.77%Consumer staples โ€” 2026 Q2: 3.83%3.83% โˆ’0.9ptUnclassified (crypto, SPACs, index)Unclassified (crypto, SPACs, index) โ€” 2026 Q1: 12.57%12.57%Unclassified (crypto, SPACs, index) โ€” 2026 Q2: 13.97%13.97% +1.4pt
Portfolio weight by theme, 2026 Q1 (estimated at current prices) vs 2026 Q2.

Frequently asked questions

What did Mangrove Partners Im LLC buy in 2026-Q2?+

The largest add was Vistance Networks, which absorbed $91.3M and became 6.01% of the book. New positions included Acadia Healthcare at $41.2M, Aptiv at $37.7M, Apartment Investment & Management at $13.2M, Greif at $7.3M and the iShares Russell 2000 ETF at $27.7M.

What is Mangrove Partners Im LLC's biggest holding?+

Indivior Pharmaceuticals is the largest position at 7.22% of the book, worth $109.8M, and sits 188.0% above the fund's average cost. Vistance Networks is second at 6.01%, followed by Atmus Filtration at 4.06%.

Did Mangrove Partners sell Ethereum in 2026-Q2?+

Yes. The Grayscale Ethereum Staking position was cut 37.2%, a reduction of $19.8M, leaving 2.2% of the book in the fund. It remains 24.9% below Mangrove's average cost.

How concentrated is Mangrove Partners' portfolio?+

The top 10 positions are 38.1% of the $1.52B 13F book, with no single holding above 7.22%. The rest is spread across roughly 50 names, including about two dozen small blank-check vehicles.

How has Mangrove Partners performed?+

The fund returned 10.48% in 2026-Q2. Over three years it has annualized 28.17% and over five years 23.5%, based on the 13F-derived coverage through 2026 Q2.

Which sectors is Mangrove Partners overweight?+

Consumer discretionary is the largest grouping at 17.62%, followed by technology at 13.54% โ€” up sharply from 5.60% โ€” and health care at 12.94%. Several of those sector tags are misleading, since payments software sits in the real-estate bucket and a midstream operator sits in utilities.

Source filings

Holdings on this page are parsed from Mangrove Partners Im LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1535392). View Mangrove Partners Im LLCโ€™s 13F filings on SEC

Other funds whose largest position is INDV

Browse all

More 13F analyses

View all